Abiopharma

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016

New Form 10-K - HARVARD BIOSCIENCE INC <b>Filed:</b> 2026-03-13 <b>AccNo:</b> 0001171843-26-001548 <b>Size:</b> 12 MB

New Form 10-K - Barinthus Biotherapeutics plc. <b>Filed:</b> 2026-03-13 <b>AccNo:</b> 0001828185-26-000012 <b>Size:</b> 10 MB

New Form 10-K - Savara Inc <b>Filed:</b> 2026-03-13 <b>AccNo:</b> 0001193125-26-105076 <b>Size:</b> 15 MB

Soleno Therapeutics Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action filed by Robbins Geller Rudman & Dowd LLP

New Form ARS - COGNEX CORP <b>Filed:</b> 2026-03-13 <b>AccNo:</b> 0001193125-26-105069 <b>Size:</b> 9 MB

Groupe Pierre & Vacances-Center Parcs: Total Number of Shares and Voting Rights

Groupe Pierre & Vacances-Center Parcs : Nombre total d’actions et de droits de vote

New Form DEFA14A - COGNEX CORP <b>Filed:</b> 2026-03-13 <b>AccNo:</b> 0001193125-26-105068 <b>Size:</b> 98 KB

HyperLight and UMC Collaborate with Jabil to Bring TFLN Photonics to Data-Center Scale Deployment

New Form S-3ASR - Corvus Pharmaceuticals, Inc. <b>Filed:</b> 2026-03-13 <b>AccNo:</b> 0001104659-26-027362 <b>Size:</b> 906 KB

Genenta, Evolving into Saentra Forge, Announces CEO’s Appointment by the Italian Government to the Board of Guarantors of the Italian Academy at Columbia University

New Form ARS - Tonix Pharmaceuticals Holding Corp. <b>Filed:</b> 2026-03-13 <b>AccNo:</b> 0001999371-26-005744 <b>Size:</b> 1 MB

NASDAQ symbol attribute type Security_Name was changed. Previous value: JIN MEDICAL INTERNATIONAL LTD. - Ordinary Shares. New value: JIN MEDICAL INTERNATIONAL LTD. - Class A Ordinary Shares.

Amber Premium Announces First 2026 English-Language Digital Asset Webinar, Building on Record Audience Growth